Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.
Suraksha Clinic and IPO
Price Band
₹420.0–441.0
Issue Size
₹846.25 Cr
Lot Size
34 shares
Min Investment
₹14,994
GMP
+₹13.0 (2.95%)
Issue Price
₹441.0
Subject to Sauda
₹300
Paid only if allotted
Suraksha Clinic and IPO AI Summary
- Suraksha Clinic and IPO is listed on BSE, NSE in the Healthcare Service Provider sector.
- Price band: ₹420.0–₹441.0 per share, lot size 34 shares (min. investment ₹14,994).
- Subscription window: 29 Nov–03 Dec 2024, listing on 06 Dec 2024.
- Current GMP is +₹13.0 (2.95%), an estimated listing price of ₹454 — unofficial and can change daily.
Suraksha Diagnostic Limited is a healthcare service provider with a comprehensive range of diagnostic services. The IPO is priced at ₹441.0, with a lot size of 34 shares and a minimum investment of ₹14,994.0. The company is well-positioned in the growing diagnostics market in eastern India, with advanced technology and a commitment to quality.
TopFund is not SEBI-registered — this is educational analysis, not personalized investment advice.
Suraksha Clinic and IPO — Third-Party Research Views
Reviews below reflect analyst calls made before this IPO closed on 03 Dec 2024 — not a current signal.
2 of 3 reviewers say Negative
Recommendations are sourced from third-party research firms and are not TopFund's own investment advice.
Important Dates
Subscription Status
Subscription data unavailable
Suraksha Clinic and IPO Grey Market Premium (GMP) Today
GMP
+₹13.0
GMP %
+2.95%
Est. Listing
₹454.0
Updated: 25 Jul 2026 14:02
About the Company
Incorporated in 2005, Suraksha Diagnostic Limited offers pathology, radiology testing and medical consultancy services. The company has a central reference laboratory with 8 satellite laboratories and 215 customer touchpoints, including 49 diagnostic centres and 166 sample collection centres as of June 30, 2024, across West Bengal, Bihar, Assam, and Meghalaya. The company offers its customers online and offline medical consultation services under one roof via 44 diagnostic centres, which house 120 polyclinics with more than 750 doctors. The operation of the diagnostic centres is supported by the technology platforms and systems that the company uses to streamline, such as its Laboratory Information Management System ("LIMS"), its fully integrated Radiology Information System ("RIS"), its Picture Archive Communication System ("PACS") and its Enterprise Resource Planning System ("ERP"). The company offers vaccination services and customized testing packages for disease prediction/early detection. The company uses digital pathology and artificial intelligence to generate blood tests. All radiology reporting is done through a digital platform that allows cases to be reported from all diagnostic centres, significantly reducing turnaround time. Competitive Strengths are: Well-positioned diagnostics chain to capture the large growth opportunities for organized diagnostics chains in the fragmented markets for diagnostic services in eastern and northeastern India. Integrated diagnostics provider offering pathology and radiology testing and medical consultancy services from a single source. Well-invested and technologically advanced clinical infrastructure. Commitment to quality driving high individual consumer business share and customer retention. Management team with relevant industry experience.
Company Financials (₹ Cr)
As of 2024-06-30
| Period Ended | 30 Jun 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|---|
| Assets | 314.20 | 300.21 | 281.20 | 275.96 |
| Total Income | 61.85 | 222.26 | 193.69 | 225.77 |
| Profit After Tax | 7.67 | 23.13 | 6.07 | 20.82 |
| NET Worth | 187.05 | 179.41 | 155.93 | 145.84 |
| Reserves and Surplus | 176.80 | 170.88 | 147.40 | 137.31 |
| Total Borrowing | 7.57 | 8.64 | 14.01 | 19.03 |
Key Ratios
EPS
₹4.44
NAV
₹33.66
ROE
14.09%
ROCE
21.46%
RoNW
14.09%
P/B Value
13.10
P/E Ratio
99.31
Market Cap
₹2296.76 Cr
PAT Margin
10.57%
Debt/Equity
0.20
Peer Comparison
| Company | NAV | RoNW | P/E (x) | EPS Basic | EPS Diluted |
|---|---|---|---|---|---|
| Vijaya Diagnostic Centre Limited | 64.21 | 19.77% | 86.4 | 11.62 | 11.59 |
| Thyrocare Technologies Ltd | 99.48 | 13.34% | 65.52 | 13.42 | 13.4 |
| Metropolis Healthcare Ltd | 213.98 | 12.26% | 89.61 | 24.95 | 24.87 |
| Dr Lalchandani Labs Ltd | 221.47 | 20.35% | 77.08 | 43.05 | 42.98 |
| Suraksha Diagnostic Limited This IPO | 33.66 | 14.09% | — | 4.43 | 4.43 |
Promoters
Somnath Chatterjee, Ritu Mittal and Satish Kumar Verma
Objects of the Issue
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects: # Issue Objects Est Amt (₹ Cr.) 1 The Company will not receive any proceeds from the Offer (“Offer Proceeds”) and all such proceeds (net of any Offer related expenses to be borne by the Selling Shareholders) will go to the Selling Shareholders.
IPO Evaluation
Generated 23 Sep 2026Revenue Trend
Total income was ₹225.77 Cr in the year ending 31 Mar 2022, declining to ₹193.69 Cr by 31 Mar 2023, before rising to ₹222.26 Cr in the year ending 31 Mar 2024. However, the most recent figure of ₹61.85 Cr as of 30 Jun 2024 is a 9-month figure, not a full year, so isn't directly comparable.
Profit Trend
Profit After Tax was ₹20.82 Cr in the year ending 31 Mar 2022, decreasing to ₹6.07 Cr by 31 Mar 2023, then increasing to ₹23.13 Cr in the year ending 31 Mar 2024. The most recent profit figure of ₹7.67 Cr as of 30 Jun 2024 is also a 9-month figure, not a full year, so isn't directly comparable.
Valuation
At the issue price of ₹441.0, Suraksha Diagnostic Limited has an implied P/E ratio of approximately 99.31, compared to peers trading at P/E ratios ranging from 65.52 to 89.61.
Grey Market Premium, Explained
The Grey Market Premium (GMP) indicates the expected listing price of an IPO based on unofficial trading in the grey market. A positive GMP suggests that the stock may list at a premium to its issue price, while a negative GMP indicates the opposite. GMP can be influenced by various factors, including market sentiment and demand for the IPO.
Who This IPO Suits
Investors comfortable with short-term volatility and a long-term horizon typically weigh IPOs like this against their investment goals and risk tolerance. It's essential to consider the company's growth potential and market conditions before making a decision.
Who May Want to Wait
Investors who are risk-averse or those looking for stable, established companies may want to avoid this IPO. It's important to assess personal investment strategies and risk appetite before participating in IPOs.
IPO Timeline, Explained
The IPO opens for subscription on 29 Nov 2024 and closes on 03 Dec 2024. Allotment of shares will be finalized by 04 Dec 2024, with the listing expected on 06 Dec 2024.
Listing Gains — The Risk
Listing gains refer to the potential profit an investor can make when an IPO shares list at a higher price than the issue price. However, these gains are not guaranteed and can vary based on market conditions and investor sentiment. It's crucial to understand that investing in IPOs carries risks, and prices can fluctuate significantly on the listing day.
This evaluation is generated from Suraksha Clinic and's own public IPO filing data for educational purposes and is not investment advice or a recommendation to apply, subscribe to, or avoid this issue — see Broker Recommendations below for named third-party research views (clearly attributed, not TopFund's own). TopFund is not a SEBI-registered investment adviser — see our Disclaimer.
Frequently Asked Questions
What is Suraksha Clinic and IPO GMP today?
Suraksha Clinic and IPO GMP today is +₹13.0 (2.95%), indicating an estimated listing price of ₹454. GMP is an unofficial grey-market indicator and can change daily.
What is the price band of Suraksha Clinic and IPO?
The price band of Suraksha Clinic and IPO is ₹420.0–₹441.0 per share.
When does Suraksha Clinic and IPO open and close?
Suraksha Clinic and IPO opens on 29 November 2024 and closes on 03 December 2024.
When does Suraksha Clinic and IPO list on the stock exchange?
Suraksha Clinic and IPO listed on 06 December 2024 at ₹454.0.
What is the lot size for Suraksha Clinic and IPO?
The lot size for Suraksha Clinic and IPO is 34 shares, requiring a minimum investment of ₹14,994.
What is the issue price of Suraksha Diagnostic Limited's IPO?
The issue price is ₹441.0.
What is the lot size for this IPO?
The lot size is 34 shares.
What is the minimum investment required?
The minimum investment required is ₹14,994.0.
When does the IPO open and close?
The IPO opens on 29 Nov 2024 and closes on 03 Dec 2024.
What does GMP mean?
GMP stands for Grey Market Premium, indicating the expected listing price of an IPO based on unofficial trading.
Issue Details
Investor Allocation
Registrar
Lead Managers / Book Running
IPO Timeline
Open
29 Nov 2024
Close
03 Dec 2024
Allotment
04 Dec 2024
Listing
06 Dec 2024
Similar IPOs in Healthcare Service Provider
Plan Your IPO Investment
Related Articles
Community Sentiment
What are other investors planning for Suraksha Clinic and?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
No comments yet — start the discussion.